As parties prepare for the second Xarelto bellwether trial in the Xarelto Multidistrict Litigation (MDL)in the Eastern District of Louisiana, the Institute of Safe Medication Practices (ISMP) has released their QuarterWatch report for the third quarter of 2016. Among the institute’s findings is an i
The long-anticipated AndroGel bellwether trial is scheduled to begin on June 5, 2017. The case is the first to go to trial in the multidistrict litigation (MDL), which was established in June 2014, in the Northern District of Illinois. That litigation has over 6,500 cases…
In March 2017, U.S. District Judge Matthew F. Kennelly met with the parties involved in the centralized testosterone replacement therapy (TRT) litigation to appoint a settlement master. The parties were instructed to attend monthly meetings to discuss potential settlement of testosterone lawsuits. N
On April 7, 2017, a North Carolina man filed a new Eliquis lawsuit on behalf of himself and his deceased wife. The case is now pending in the Southern District of New York, the court in which all federally filed Eliquis lawsuits have been centralized.…
In April 2017, the first bellwether trial in Xarelto Multidistrict Litigation (MDL) was tried. The Xarelto MDL is located in the Eastern District of Louisiana, which is where the first trial took place. The lawsuit was filed by a man who claimed to have started…
A Virginia woman has joined the Xarelto multidistrict litigation in the Eastern District of Louisiana. She filed her case on March 20, 2017, and claims that her husband suffered serious injuries and died after taking Xarelto. She seeks $2 million in damages. Man Suffers from…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits in one court in the Eastern District of Louisiana. Since then, both sides have been working toward preparing a small number of cases for bellwether trials to gauge…
A Texas man filed a new lawsuit against Bristol-Myers Squibb and Pfizer, Inc., manufacturers of the blood-thinning drug Eliquis. He filed as Personal Representative of his wife’s Estate, whom he claims passed away as a result of taking Eliquis. The case was filed on March…
The FDA has announced Mylan’s expanded recall of select lots of its EpiPen Auto-Injector and EpiPen Jr. Auto-Injector. This follows the original recall that the company announced in March 2017. Initially, they recalled units sold only in Australia, due to a potentially defective part that…
If you’re over the age of 60, you’ve probably been told that it’s time to start thinking about the shingles vaccine, Zostavax. This vaccine is intended to help reduce the risk of shingles. For those who develop the condition despite being immunized, Zostavax may help…
According to the FDA, if you have gone through a surgical procedure to remove your gallbladder, you shouldn’t be using Viberzi (eluxadoline), a prescription drug treatment for irritable bowel syndrome (IBS). In a recent drug safety communication, the FDA warned that Viberzi can increase the…
Testosterone replacement manufacturer AbbVie wants to dismiss testimony from plaintiffs’ experts in consolidated testosterone litigation. In a motion filed on February 20, 2017, the defendants requested that U.S. District Judge Matthew F. Kennelly, who is overseeing centralized proceedings in the No